FIELD: chemistry.
SUBSTANCE: proposed here is an isolated cyclic peptide, with amino acid sequence Cys-Ile-Xaa-Ser-Cys (SEQ ID NO:7); where Xaa is an amino acid residue, chosen from a group comprising Asp, Asn, Glu and Gin, and containing a disulphide bond between two Cys residues, which can be used as a selective antagonist of R-cadherin of mammals.
EFFECT: invented selective peptide-antagonists of R-cadherin can be used for inhibiting targeting of hematopoietic stem cells (HSC) on a developing vascular tree, for inhibiting cytoadherence caused by R-cadherin and inhibiting retina angiogenesis.
8 cl, 12 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITORS FOR USING IN HEMOSTASIS AND IMMUNE FUNCTION | 2000 |
|
RU2239449C2 |
| ISOLATED POPULATIONS OF MYELOID-LIKE CELLS OF BONE MARROW AND METHODS OF TREATMENT WITH THEM | 2006 |
|
RU2418856C2 |
| METHOD OF TREATING RETINOPATHY IN PREMATURITY AND RELATED RETINOPATHIC DISEASES | 2006 |
|
RU2403906C2 |
| PEPTIDES FOR INHIBITING ANGIOGENESIS | 2016 |
|
RU2708375C2 |
| TECHNIQUES AND COMPOSITIONS USED TO INHIBIT αβ-CAUSED ANGIOGENESIS | 1997 |
|
RU2195312C2 |
| RECOVERED MYELOID-LIKE CELL POPULATIONS AND METHOD OF TREATING WITH USING SUCH POPULATIONS | 2007 |
|
RU2473686C2 |
| HAEMATOPOIETIC STEM CELLS AND METHODS OF TREATING NEOVASCULAR OPHTHALMOPATHIES WITH USING THEREOF | 2006 |
|
RU2389497C2 |
| HEMATOPOETIC STEM CELLS AND METHODS OF TREATMENT OF NEOVASCULAR EYE DISEASES USING THEREOF | 2004 |
|
RU2345780C2 |
| PEPTIDES OF DIRECTED ACTION OF VEGFR-1/NRP-1 | 2008 |
|
RU2488592C2 |
| METHODS AND COMPOSITIONS USED FOR INHIBITING ANGIOGENESIS | 1997 |
|
RU2194528C2 |
